The incidence and mortality of small-cell lung cancer worldwide make this disease a notable
health-care issue. Diagnosis relies on histology, with the use of immunohistochemical …

With the emergence of individualized medicine and the increasing amount and complexity
of available medical data, a growing need exists for the development of clinical decision-…

… Bentzen, Johan Vansteenkiste, Philippe Lambin Provision of study materials or patients:
Dirk De Ruysscher, Madelon Pijls-Johannesma, Søren M.Bentzen, André Minken, Rinus …

Background Recently, immunologic responses to localized irradiation are proposed as
mediator of systemic effects after localized radiotherapy (called the abscopal effect). Here, we …

Radiotherapy is used in >50% of patients with cancer, both for curative and palliative purposes.
Radiotherapy uses ionizing radiation to target and kill tumour tissue, but normal tissue …

A collaboration of multidisciplinary experts on the functional evaluation of lung cancer
patients has been facilitated by the European Respiratory Society (ERS) and the European …

Primary lung cancer is the most common malignancy after nonmelanocytic skin cancer with
deaths from lung cancer exceeding those from any other type of malignancy worldwide [1]. …

An estimated 1.6 million new lung cancers are diagnosed worldwide each year. The highest
incidence rates in males are observed in Central/Eastern and Southern Europe (57 and 49 …

A high proportion of NSCLC patients present with symptoms in advanced disease stage. The
aim of lung cancer screening is to reduce lung cancer-related mortality by detecting more …

To complement the existing treatment guidelines for all tumour types, ESMO organises
consensus conferences to focus on specific issues in each type of tumour. The 2nd ESMO …